Skip to main content
. 2018 May 29;8:8194. doi: 10.1038/s41598-018-26519-w

Figure 3.

Figure 3

Reduction in the frequency of T cells expressing pro-inflammatory cytokines after 12 m of DMF treatment. Frequency of CD4+ T cells expressing pro-inflammatory cytokines (a), including IFN-γ, GM-CSF, IL-17 or anti-inflammatory cytokines (b), including IL-4 and IL-10, in RRMS patients at baseline and after 12 m of DMF treatment (n = 12). Each line represents an individual patient and average values are depicted as histograms. Wilcoxon matched-pairs signed rank test was used to determine p values. *p < 0.05, **p < 0.01, ***p < 0.001. IFN-γ = interferon γ, GM-CSF = granulocyte macrophage colony-stimulating factor, IL-17 = interleukin-17, IL-4 = interleukin-4, IL-10 = interleukin-10, m = months.